Clinical trial
Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
NCT07073469 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- September 1, 2025
- Completion date
- November 1, 2027
- Enrollment
- 330 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
stroke ischemic